Search Results - "Ruiz León, B"

Seasonal Administration of Omalizumab in Patients With Uncontrolled Asthma and Sensitization to Olive Pollen by Serrano, P, Navas, A, Ruiz-León, B, Herrero, L, Rondón, C, Jurado, A, Moreno-Aguilar, C

“…Sensitization to olive pollen leads to the development of asthma. In areas with high pollen counts, such as the southern Mediterranean, sensitization to Ole e…”
Get full text

Successful Adaptation of Bee Venom Immunotherapy in a Patient Monosensitized to Api m 10 by Ruiz-León, B, Navas, A, Serrano, P, Espinazo, M, Labrador-Horrillo, M, Monsalve, RI, Jurado, A, Moreno-Aguilar, C

“…Bee venom immunotherapy (BVIT), although highly effective, does not protect 10%-15% of patients allergic to bee stings. Even though the production of…”
Get full text

Large Local Reactions to Hymenoptera Stings Negatively Affect Quality of Life to the Same Degree as Systemic Reactions by Sánchez-Morillas, L, Alfaya Arias, T, Martínez San Ireneo, M, Domínguez Noche, C, Vega Gutierrez, J M, Vega Castro, A, Moreno Mata, E, Marqués, L, Fuentes Ferrer, M, Ruiz-León, B

Get full text

Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain by Gutiérrez Fernández, D, Moreno-Ancillo, A, Fernández Meléndez, S, Domínguez-Noche, C, Gálvez Ruiz, P, Alfaya Arias, T, Carballada González, J, F, Alonso Llamazares, A, Marques Amat, L, L, Vega Castro, A, Antolín Amérigo, D, Cruz Granados, S, Ruiz León, B, Sánchez Morillas, L, Fernández Sánchez, J, Soriano Gomis, V, Borja Segade, M, J, Dalmau Duch, G, Guspi Bori, R, Miranda Páez, A

“…Hymenoptera venom immunotherapy (VIT) is an effective treatment but not one devoid of risk, as both local and systemic adverse reactions may occur, especially…”
Get full text

PP-020 Controversies in the conducting of drug patch testing by Arroyo, P Araque, Lluch, T Gómez, García, MC Conde, León, B Ruiz, Montero, A Burgos, Gámez, JC Valenzuela

“…BackgroundThe drug patch test (DPT) is useful as a tool for diagnosing delayed hypersensitivity skin reactions to medications. However, there is no consensus…”
Get full text

Helios-Negative Regulatory T Cells as a Key Factor of Immune Tolerance in Nonallergic Beekeepers by Ruiz-Leon, B, Navas, A, Serrano, P, Espinazo, M, Guler, I, Alonso, C, Jurado, A, Moreno-Aguilar, C

“…Although exposure to stings has been identified as the leading risk factor for anaphylaxis due to Hymenoptera venom allergy, professional beekeepers receive…”
Get full text

Key Issues in Hymenoptera Venom Allergy: An Update by Alfaya Arias, T, Soriano Gómis, V, Soto Mera, T, Vega Castro, A, Vega Gutiérrez, J M, Alonso Llamazares, A, Antolín Amérigo, D, Carballada Gonzalez, F J, Dominguez Noche, C, Gutierrez Fernandez, D, Marques Amat, L, Martinez Arcediano, A, Martinez San Ireneo, M, Moreno Ancillo, A, Puente Crespo, Y, Ruiz Leon, B, Sánchez Morillas, L

“…In this review, the Hymenoptera Allergy Committee of the SEAIC analyzes the most recent scientific literature addressing problems related to the diagnosis of…”
Get full text

Successful adaptation of bee venom immunotherapy for a monosensitized patient to Api m 10 by Ruiz-León, B, Navas, A, Serrano, P, Espinazo, M, Labrador-Horrillo, M, Monsalve, R I, Jurado, A, Moreno-Aguilar, C

Get full text

The Lights and the Shadows of Controlled Sting Challenge With Hymenoptera by Ruiz-León, B, Martínez San Ireneo, M, de la Roca, F, Arenas, L, Alfaya Arias, T, Cordobés, C, Marqués, L, Vega, A, Moreno-Aguilar, C

“…Hymenoptera venom immunotherapy (VIT) is effective for protecting individuals with systemic allergic reactions caused by Hymenoptera stings. The need for a…”
Get full text

D12 MECHANISMS OF ALLERGIC AIRWAY INFLAMMATION: Location Dependent Signals Fine-Tune Dendritic Cell Control Of Th2 Responses by Curtiss, M L, Ptacek, T, Leon-Ruiz, B, Ballesteros-Tato, A, Randall, T, Lund, F

“…In a mouse infection model with the nematode Heligmosomoidespolygurus (HP), development of Th2 responses requires T cell:DC interactions in the perifollicular…”
Get full text

Influencing factors on the safety and effectiveness of venom immunotherapy by Arzt-Gradwohl, L, Annik Herzog, S, Aberer, W, Alfaya Arias, T, Antolín-Amérigo, D, Bonadonna, P, Boni, E, Bożek, A, Chełmińska, M, Ernst, B, Frelih, N, Gawlik, R, Gelincik, A, Hawranek, T, Hoetzenecker, W, Jiménez Blanco, A, Kita, K, Kendirlinan, R, Košnik, M, Laipold, K, Lang, R, Marchi, F, Mauro, M, Nittner-Marszalska, M, Poziomkowska-Gęsicka, I, Pravettoni, V, Preziosi, D, Quercia, O, Reider, N, Rosiek-Biegus, M, Ruiz-Leon, B, Schrautzer, C, Serrano, P, Sin, A, Ayşe Sin, B, Stoevesandt, J, Trautmann, A, Vachová, M, Johannes Sturm, G

“…Objectives: The safety profile of venom immunotherapy (VIT) is a relevant issue and considerable differences in safety and efficacy of VIT have been reported…”
Get full text